S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
NASDAQ:JAZZ

Jazz Pharmaceuticals Price Target, Predictions & Analyst Ratings

$141.83
-1.00 (-0.70 %)
(As of 11/25/2020 05:00 PM ET)
Add
Compare
Today's Range
$141.02
Now: $141.83
$144.00
50-Day Range
$140.79
MA: $148.22
$157.33
52-Week Range
$86.88
Now: $141.83
$158.98
Volume361,355 shs
Average Volume679,093 shs
Market Capitalization$7.90 billion
P/E Ratio44.74
Dividend YieldN/A
Beta1.17

Analyst Ratings

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for Jazz Pharmaceuticals in the last 12 months. Their average twelve-month price target is $172.12, predicting that the stock has a possible upside of 21.35%. The high price target for JAZZ is $233.00 and the low price target for JAZZ is $113.00. There are currently 1 sell rating, 1 hold rating and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
JAZZ Consensus Rating: BuyBuyBuyBuy
JAZZ Consensus Rating Score: 2.822.832.892.68
JAZZ Analyst Ratings: 1 Sell Rating(s)
1 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
JAZZ Consensus Price Target: $172.12$168.53$164.13$156.22
JAZZ Price Target Upside: 21.35% upside29.81% upside40.64% upside31.66% upside

Jazz Pharmaceuticals (NASDAQ:JAZZ) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Jazz Pharmaceuticals (NASDAQ:JAZZ) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2020Wells Fargo & CompanyBoost Price TargetOverweight$171.00 ➝ $184.00High
11/3/2020Royal Bank of CanadaBoost Price TargetOutperform$170.00 ➝ $180.00High
11/3/2020BarclaysBoost Price TargetOverweight$225.00 ➝ $233.00High
11/3/2020SVB LeerinkBoost Price TargetOutperform$194.00 ➝ $202.00High
11/3/2020HC WainwrightBoost Price TargetBuy$185.00 ➝ $195.00High
10/20/2020TruistBoost Price Target$157.00 ➝ $175.00Medium
10/9/2020Jefferies Financial GroupBoost Price TargetBuy$151.00 ➝ $188.00Low
9/14/2020JPMorgan Chase & Co.Initiated CoverageOverweight$175.00Medium
9/14/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$128.00Medium
8/6/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$177.00High
7/30/2020OppenheimerInitiated CoverageOutperformHigh
7/28/2020Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
6/18/2020Bank of AmericaBoost Price TargetBuy$165.00 ➝ $167.00Low
5/6/2020SunTrust BanksLower Price TargetBuy$155.00 ➝ $153.00Medium
5/6/2020BMO Capital MarketsLower Price TargetPositive ➝ Outperform$205.00 ➝ $193.00High
5/6/2020Piper SandlerLower Price TargetNeutral$127.00 ➝ $113.00High
3/12/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$175.00 ➝ $166.00High
2/26/2020CowenLower Price TargetOutperform$200.00 ➝ $165.00High
11/11/2019Evercore ISIReiterated RatingBuyMedium
8/21/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$205.00 ➝ $142.00High
7/3/2019MizuhoSet Price TargetHold$148.00Low
3/26/2019Cantor FitzgeraldReiterated RatingBuy$185.00Medium
11/8/2018B. RileyLower Price TargetBuy ➝ Buy$219.00 ➝ $190.00Medium
8/9/2018Seaport Global SecuritiesReiterated RatingBuy$207.00Low
8/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$180.00 ➝ $205.00High
7/10/2018CitigroupBoost Price TargetBuy ➝ Buy$162.00 ➝ $205.00Low
1/16/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$170.00Medium
(Data available from 11/25/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.